PAIAR, FABIOLA
 Distribuzione geografica
Continente #
NA - Nord America 13.023
AS - Asia 6.756
EU - Europa 4.341
SA - Sud America 1.272
AF - Africa 360
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 25.773
Nazione #
US - Stati Uniti d'America 12.739
CN - Cina 2.341
SG - Singapore 1.940
IT - Italia 1.546
HK - Hong Kong 1.072
BR - Brasile 1.026
VN - Vietnam 655
SE - Svezia 557
DE - Germania 379
BG - Bulgaria 354
FR - Francia 287
GB - Regno Unito 273
AT - Austria 205
RU - Federazione Russa 199
FI - Finlandia 198
CA - Canada 184
IN - India 115
CI - Costa d'Avorio 106
JP - Giappone 104
TR - Turchia 89
AR - Argentina 87
BD - Bangladesh 73
NL - Olanda 71
ZA - Sudafrica 62
ID - Indonesia 55
KR - Corea 54
MX - Messico 51
PL - Polonia 50
SN - Senegal 41
IQ - Iraq 40
NG - Nigeria 38
VE - Venezuela 37
EC - Ecuador 36
PK - Pakistan 33
MA - Marocco 31
IE - Irlanda 29
CO - Colombia 25
ES - Italia 23
UA - Ucraina 23
UZ - Uzbekistan 23
CZ - Repubblica Ceca 21
SA - Arabia Saudita 20
BE - Belgio 19
KE - Kenya 19
CL - Cile 18
CH - Svizzera 17
MY - Malesia 15
PY - Paraguay 15
IL - Israele 14
EG - Egitto 13
PH - Filippine 13
RO - Romania 12
DZ - Algeria 11
RS - Serbia 10
TN - Tunisia 10
UY - Uruguay 10
AU - Australia 9
AZ - Azerbaigian 9
CR - Costa Rica 9
HU - Ungheria 9
LB - Libano 9
PE - Perù 9
PT - Portogallo 9
TW - Taiwan 9
BO - Bolivia 8
JO - Giordania 8
LT - Lituania 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
HN - Honduras 7
IR - Iran 7
OM - Oman 7
AE - Emirati Arabi Uniti 6
EE - Estonia 6
GT - Guatemala 6
JM - Giamaica 6
NO - Norvegia 6
AL - Albania 5
CY - Cipro 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
GA - Gabon 4
GR - Grecia 4
LV - Lettonia 4
NP - Nepal 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
LA - Repubblica Popolare Democratica del Laos 3
MG - Madagascar 3
ML - Mali 3
NZ - Nuova Zelanda 3
PA - Panama 3
TH - Thailandia 3
HR - Croazia 2
PR - Porto Rico 2
Totale 25.736
Città #
Ashburn 1.251
Shanghai 1.213
Woodbridge 1.174
Fairfield 1.113
Hong Kong 1.065
Singapore 1.065
San Jose 893
Houston 874
Ann Arbor 843
Dallas 825
Santa Clara 688
Chandler 584
Seattle 476
Cambridge 399
Wilmington 388
Sofia 350
New York 323
Beijing 322
Boardman 218
Los Angeles 199
Ho Chi Minh City 192
Vienna 192
Pisa 162
Florence 154
Princeton 149
Lawrence 137
Lauterbourg 134
Munich 132
London 128
Medford 126
Serra 113
Abidjan 106
Des Moines 99
Hanoi 99
Ottawa 96
Tokyo 91
Frankfurt am Main 89
Rome 86
São Paulo 80
Milan 78
Redondo Beach 75
Buffalo 69
Turku 66
Dearborn 62
Dong Ket 59
Vicopisano 59
Council Bluffs 57
Istanbul 55
Hefei 54
Lucca 49
San Diego 47
Nanjing 46
Cascina 42
Dakar 41
Düsseldorf 40
Seoul 40
Lancaster 39
Pietrasanta 39
Warsaw 39
Lagos 38
Helsinki 33
Fuzhou 31
Bremen 30
Orem 30
Toronto 30
Amsterdam 29
Rio de Janeiro 29
Boulder 28
Chicago 28
Montreal 28
Cape Town 27
Da Nang 25
Phoenix 25
San Francisco 25
Belo Horizonte 23
Denver 23
Baghdad 22
Ogden 22
Quanzhou 22
Tashkent 22
Columbus 21
Curitiba 21
Porto Alegre 21
Haiphong 20
Bientina 19
Dublin 19
Guangzhou 19
Atlanta 18
Brasília 18
Poplar 18
Redwood City 18
Chennai 17
Johannesburg 17
Massa E Cozzile 17
Nairobi 17
Paris 17
Brooklyn 16
Manchester 16
Shenyang 16
The Dalles 16
Totale 18.615
Nome #
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 785
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 284
From a waiting list to a priority list: A computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy 261
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 252
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 239
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 238
Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 237
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 213
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 204
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 199
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature 197
Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: Preliminary findings 196
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 195
NAVIGATOR: A regional multimodal imaging biobank initiative powered by AI tools for precision medicine in oncology 188
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study 188
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 186
Contouring of the pharyngeal superior constrictor muscle (PSCM): a cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 185
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 184
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 183
Prognostic role of internal jugular vein preservation in neck dissection for head and neck cancer 181
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis 178
Hypofractionation in prostate cancer: Radiobiological basis and clinical appliance 177
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery 175
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 175
Subtotal supracricoid laryngectomy: Changing in indications, surgical techniques and use of new surgical devices 173
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 173
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 172
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 170
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 169
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 168
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 166
Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients 166
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance? 165
Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial 165
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives 164
Non-melanoma skin cancer treated with high-doserate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 164
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 164
Adjuvant chemoradiotherapy (gemcitabine-based) in pancreatic adenocarcinoma: The Pisa University experience 163
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease 162
IOERT in Breast Cancer: Results of Ten-Year Follow-Up in an Italian Experience Confirm High Local Recurrence Rate 161
Benefit of Radiation Boost After Whole-Breast Radiotherapy 160
Accelerated Partial Breast Irradiation With IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial 160
Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy 160
Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: A single center experience 159
Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review" 159
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer 158
Adjuvant trastuzumab in breast cancer: Experience from the University of Florence 157
Different timing to use bevacizumab in patients with recurrent glioblastoma: Early versus delayed administration 157
Surface imaging, portal imaging, and skin marker set-up vs. CBCT for radiotherapy of the thorax and pelvis 156
Treatment of epithelioid sarcoma at the Royal Marsden Hospital 155
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 155
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 155
Breast cancer in the elderly: Treatment of 1500 patients 154
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment 151
Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes 151
Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol 151
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 151
Head and neck radiotherapy amid the COVID‑19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 151
Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments 151
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 149
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998 148
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 148
Surgical options in radiotherapy-failed early glottic cancer 148
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point? 148
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 148
High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience 148
New insights on clinical perspectives of FLASH radiotherapy: from low- to very high electron energy 147
Single-fraction flattening filter–free volumetric modulated arc therapy for lung cancer: Dosimetric results and comparison with flattened beams technique 147
Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience 147
Treatment of uterine sarcoma at the University of Florence from 1980-2001 146
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 146
Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer 146
Radiation-Related Dysphagia: From Pathophysiology to Clinical Aspects 146
The effects of radiation therapy fractionation on the sparing of healthy tissue in FLASH radiotherapy 145
A new calculation method for the free electron fraction of an ionization chamber in the ultra-high-dose-per-pulse regimen 145
null 145
Electron FLASH radiotherapy in vivo studies. A systematic review 144
Uterine sarcoma: twenty-seven years of experience 144
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 144
Bipolar disorder treatments and ovarian cancer: A systematic review 144
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease 143
Quality of life after radical treatment of prostate cancer: Validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index 143
Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy 142
Circulating tumour cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival 142
Squamous cell carcinoma (SCC) of the Pyriform sinus with multiple metachronous brain metastases, a case report 142
Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only 141
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: A single center experience 141
How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 140
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 140
Radiomics and liquid biopsy in oncology: the holons of systems medicine 140
A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma 139
Radiotherapy in the COVID-19 Pandemic Era 139
Adjuvant radiotherapy in patients with pancreatic adenocarcinoma. Is it still appealing in clinical trials? A meta-analysis and review of the literature 139
A new solution for UHDP and UHDR (Flash) measurements: Theory and conceptual design of ALLS chamber 139
Regional Oncotherapies 138
Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients With Breast Cancer: Implications for Supraclavicular Nodal Irradiation 138
Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer 137
Loco regional failure pattern after lumpectomy and breast irradiation in 4185 patients with T1 and T2 breast cancer. Implications for nodal irradiation 137
Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy 137
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 135
Totale 16.981
Categoria #
all - tutte 74.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 0 175
2021/20221.518 36 60 25 69 277 231 56 83 78 50 122 431
2022/20232.166 246 287 169 147 247 285 26 153 399 9 164 34
2023/20241.458 82 114 149 226 150 273 66 50 44 52 75 177
2024/20256.323 95 204 60 331 447 589 1.310 264 608 702 643 1.070
2025/20267.616 438 1.049 943 941 746 553 961 400 414 802 295 74
Totale 26.207